about
sameAs
Targeting KSHV/HHV-8 latency with COX-2 selective inhibitor nimesulide: a potential chemotherapeutic modality for primary effusion lymphomaThe Role of PPARgamma Receptors and Leukotriene B(4) Receptors in Mediating the Effects of LY293111 in Pancreatic CancerTargeted therapy for hepatocellular carcinoma: novel agents on the horizonAspirin induces apoptosis in oesophageal cancer cells by inhibiting the pathway of NF-kappaB downstream regulation of cyclooxygenase-2The historical analysis of aspirin discovery, its relation to the willow tree and antiproliferative and anticancer potentialAspirin and lung cancer risk in a cohort study of women: dosage, duration and latencyEarly Carcinogenesis Involves the Establishment of Immune Privilege via Intrinsic and Extrinsic Regulation of Indoleamine 2,3-dioxygenase-1: Translational Implications in Cancer Immunotherapy.Coexpression of VEGF-C and COX-2 and its association with lymphangiogenesis in human breast cancer.Multimodal therapy for synergic inhibition of tumour cell invasion and tumour-induced angiogenesisCOX-2 inhibition improves immunotherapy and is associated with decreased numbers of myeloid-derived suppressor cells in mesothelioma. Celecoxib influences MDSC function.Polymorphisms in regulatory regions of cyclooxygenase-2 gene and breast cancer risk in Brazilians: a case-control studyGallbladder cancer predisposition: a multigenic approach to DNA-repair, apoptotic and inflammatory pathway genes.Microvessel density is a prognostic marker of human gastric cancer.Intake of polyunsaturated fatty acids and distal large bowel cancer risk in whites and African Americans.Pathological aspects of lipid peroxidation.Use of aspirin and other nonsteroidal antiinflammatory medications in relation to prostate cancer riskElevated dietary linoleic acid increases gastric carcinoma cell invasion and metastasis in miceNew insights into the health effects of dietary saturated and omega-6 and omega-3 polyunsaturated fatty acidsThe role of the RB tumour suppressor pathway in oxidative stress responses in the haematopoietic system.Prevalence and risk factors for cervical neoplasia: a cervical cancer screening program in Beijing.Effects of the black tea polyphenol theaflavin-2 on apoptotic and inflammatory pathways in vitro and in vivo.Dose-risk and duration-risk relationships between aspirin and colorectal cancer: a meta-analysis of published cohort studies.The role of intraprostatic inflammation in the acute urinary retentionInduction of cyclooxygenase-2 expression by hepatitis B virus depends on demethylation-associated recruitment of transcription factors to the promoterFrequency-risk and duration-risk relationships between aspirin use and gastric cancer: a systematic review and meta-analysisNonsteroidal antiinflammatory drugs and bladder cancer: a pooled analysisCannabinoids and cancer: pros and cons of an antitumour strategy.Aspirin use and the risk of prostate cancer: a meta-analysis of 24 epidemiologic studies.Can daily intake of aspirin and/or statins influence the behavior of non-muscle invasive bladder cancer? A retrospective study on a cohort of patients undergoing transurethral bladder resectionAspirin use and lung cancer risk: a possible relationship? Evidence from an updated meta-analysis.Positive feedback between PGE2 and COX2 redirects the differentiation of human dendritic cells toward stable myeloid-derived suppressor cells.Genetic variation in inflammatory pathways is related to colorectal cancer survival.Long term NSAID treatment inhibits COX-2 synthesis in the knee synovial membrane of patients with osteoarthritis: differential proinflammatory cytokine profile between celecoxib and aceclofenacCyclooxygenase-2 and Ki67 Expression in Oral Leukoplakia: a Clinicopathological Study.Association between 8473T>C polymorphism in the cyclooxygenase-2 gene and the risk of nasopharyngeal carcinoma.COX-2 promotes metastasis in nasopharyngeal carcinoma by mediating interactions between cancer cells and myeloid-derived suppressor cells.Surgery and stress promote cancer metastasis: new outlooks on perioperative mediating mechanisms and immune involvementMechanisms of disease: Prostate cancer--a model for cancer chemoprevention in clinical practice.The effects of a cyclooxygenase-2 (COX-2) expression and inhibition on human uveal melanoma cell proliferation and macrophage nitric oxide production.Isoliquiritigenin Inhibits Metastatic Breast Cancer Cell-induced Receptor Activator of Nuclear Factor Kappa-B Ligand/Osteoprotegerin Ratio in Human Osteoblastic Cells.
P2860
Q21135231-B4A1A221-1DED-429A-8FD2-4D56E6F1F893Q21342813-2E3FCBEE-3D4D-4C46-B97B-D6399C95C6A8Q27002288-8D6074CF-7CE3-4A36-AE38-D49F85465BC2Q28193816-89A059EF-70F2-42FD-B035-068957073D49Q28195754-1456D78B-76E3-4F0B-A06E-2DBA1FC400C2Q28222207-0D21ADE7-A349-4D70-A08F-EA060853E732Q30410002-35D10056-EC47-4459-B98C-A6C0AAF911EFQ33314445-5B77F349-B1B0-42F0-B50E-6AD3FF8BC7CFQ33539986-5707F1FF-F293-4094-B918-30197FA595F8Q33678308-6B0638B5-5AE6-4E71-B64A-EBF942EF3E29Q33741123-F87506C1-CF79-477A-A63A-9F29B076E4DAQ33808898-0AE5A15E-D1B1-487F-9BEC-161991C57305Q33868722-4912FD45-14A7-4EA5-946F-A6989FFDE88BQ33880883-F5706044-35A2-4A6E-9141-EDDD94845710Q34137628-CF09B3A4-B3A5-47DC-8C3B-87ADE3900F34Q34179634-F24C63D4-0CE1-4867-B585-7001B9E01C00Q34255969-25A92319-810F-4E33-974D-43BBE7C10D23Q34276404-9DA56A45-17DB-4C8C-82A4-7936F2E2505CQ34341080-8307730C-14DB-4C54-B022-679E1998AA73Q34448648-505085B1-78E0-4D6D-B738-4CD18B086679Q34551396-B7140CB4-C9E9-4E5A-B3D4-8BFDF5E21EDAQ34603649-C1801D2F-A710-4426-BD28-252BB345A03CQ34714167-66CB8017-FDA6-4642-914B-155D1563DBCDQ34732677-FE61C248-4C66-48F1-AF05-5113BB6BBFE4Q34923812-322C175B-5D38-45BE-B131-6C3CB3BC896CQ35017482-90C06917-BFF0-4AAE-8DF6-24EBF3AEDE7AQ35100892-3790E041-12BF-4AC9-BDB6-75F6BD633828Q35136401-04892A7B-686A-454D-9A49-D5AF038B1065Q35204387-5060499A-ADAE-42B9-B5C8-583C75EECD1EQ35306580-ABF98546-B866-4937-8303-02EB9E855AA9Q35553327-80EFEA42-A750-47BC-9F0B-DB7DC3E2A927Q35556219-C7776CA2-E65A-43C4-BF58-7CA15B948932Q35637500-F1306B37-B65B-41D2-90CE-CF69780AE67FQ35894496-629811D5-72B7-4595-900A-9BD0D8418F14Q35919516-8F3C85A1-DE9A-469B-90A1-BB27562F6769Q36110362-F5D0AA0D-4CFB-4D03-A951-E499C7CA6E57Q36177081-825C357B-23DE-4857-B52B-392C607510FAQ36304000-BFE77278-53CF-4F86-8346-66350C325C15Q36419349-32493B8E-BFF4-4CF4-918C-0F60FBE8A63FQ36426121-07D44D6B-B54B-446E-B828-EC8B9EEDEC40
P2860
description
2004 nî lūn-bûn
@nan
2004 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
name
Cyclooxygenases in cancer: progress and perspective
@ast
Cyclooxygenases in cancer: progress and perspective
@en
Cyclooxygenases in cancer: progress and perspective
@nl
type
label
Cyclooxygenases in cancer: progress and perspective
@ast
Cyclooxygenases in cancer: progress and perspective
@en
Cyclooxygenases in cancer: progress and perspective
@nl
prefLabel
Cyclooxygenases in cancer: progress and perspective
@ast
Cyclooxygenases in cancer: progress and perspective
@en
Cyclooxygenases in cancer: progress and perspective
@nl
P2093
P1433
P1476
Cyclooxygenases in cancer: progress and perspective
@en
P2093
Vasan Yegnasubramanian
William B Isaacs
William G Nelson
P356
10.1016/J.CANLET.2004.06.014
P407
P577
2004-11-01T00:00:00Z